New AAA Stent Graft Approval for Medtronic

Medtronic, Inc. (NYSE: MDT) has announced the U.S. and European approval and launch of its latest stent graft system for the endovascular repair of abdominal aortic aneurysms: the Endurant IIs. This newest iteration of the widely-used Endurant endograft (nearly 1 out of every 2 procedures are done with the Endurant) features a three-piece system with a shorter ipsilateral leg, allowing the device to accommodate more anatomical variations.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news